Comparison of doublet and triplet therapies for metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis

BACKGROUND: The best choice of first-line treatment for metastatic hormone-sensitive prostate cancer (mHSPC) is unclear. We aimed to compare the effectiveness and safety determined in randomized clinical trials of doublet and triplet treatments for mHSPC. METHODS: Medline, Embase, Cochrane Central a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lei, Li, Chunxing, Zhao, Zichen, Li, Xiaojian, Tang, Chong, Guan, Zhenpeng, Sun, Feng, Gu, Jin, Li, Ningchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028133/
https://www.ncbi.nlm.nih.gov/pubmed/36959793
http://dx.doi.org/10.3389/fonc.2023.1104242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028133/
https://www.ncbi.nlm.nih.gov/pubmed/36959793
http://dx.doi.org/10.3389/fonc.2023.1104242

Ejemplares similares